We develop experimental and computational methods to study tumor ecosystems at single-cell level and explore how to target cancer cells @DQBM_uzh and @ETH_DBIOL
Delighted to share our @naturemethods paper on high-resolution #ImagingMassCytometry! HR-IMC breaks the 1 µm barrier to reveal subcellular features in tissue. 🔬
A step forward for #SpatialBiology
https://t.co/vUwfQnAycV
For those interested in the evolution and possible future directions of imaging-based spatial proteomics, I recommend reading our perspective article.
https://t.co/PYOctTbytm
Our review on Highly Multiplexed Tissue Imaging in Precision Oncology is now live in Cancer Discovery! We discuss imaging modalities, their clinical pros/cons, and paths for implementation.@CD_AACR#Spatialomics https://t.co/r5lhySizZA
Congratulations: Dr. Lena Cords receives the German Study Prize by the Körber Foundation!👏
Her research on cancer-associated #fibroblasts offers new options for #cancer#therapy.
👉 https://t.co/Zs3J2w4De9📝
In Detail:
🌟Dr. @lenacords developed a new classification system for cancer-associated fibroblasts (CAFs).
🌟Her research shows that different CAF types can either support or suppress tumor growth, impacting patient prognosis and therapy outcomes.
About Dr. Lena Cords & the award:
🏆Dr. Lena Cords, has been awarded the German Study Prize by the Körber Foundation, @KoerberScience, in the category of natural & technical sciences for her doctoral thesis at @UZH_en & @ETH_en.
🌟The prize is endowed with 25,000 euros.
👩🔬Dr. Lena Cords is now working in @SchillerLab, #HelmholtzMunich, dissecting mechanisms of lung fibrosis.
@BodenmillerLab
#CancerResearch #GermanStudyPrize #Oncology #PrecisionMedicine
Very excited to have presented our work during the 2024 Nobel Symposia “Spatial Biology In The Genomics Era” at the @ScienceAcad in Stockholm alongside leaders in the field of #spatialbiology and #precisionmedicine.
Opportunities and challenges of #precisiononcology: Andreas Wicki and Bernd discuss the power of technology, cost effectiveness, and regulations in the latest #StrategyandInsider podcast episode. Find out how technology and data help in fighting #cancer: https://t.co/7pABOkxIcQ
After months of dedicated training, @BodenmillerLab is thrilled to stand at the start line of #SOLA2024 relay race this Saturday. 113 kilometers, 14 BB Lab members, 1 goal. Come and cheer us on as we’re giving our everything to finish among top 100 fastest teams!
What's the future of cancer treatment? It’s here...
Hear how the @BodenmillerLab is using Imaging Mass Cytometry™ to provide personalized treatment recommendations based on molecular data while improving overall response rates and patient outcomes: https://t.co/BWm1tGlqsD
It’s been two months since we joined #ESMOIO2023!
We proudly presented the latest @IMMUcan#cancerresearch.
But what exactly did we bring to the table during those days in early December 2023? Let’s look back!
This week, we highlight Daniel Schulz and team!
Welcome Simon Haefliger, our new PhD student! Simon is a MD and previously worked at @UniSpitalBasel. He will work on a rare #sarcoma called #ClearCellSarcoma. Great to have you in our lab! Have a good start @DQBM_uzh
In this Review, de Souza, Zhao & Bodenmiller (@BodenmillerLab) discuss how advances in the high-plex imaging of protein markers at the single-cell & subcellular level has expanded our understanding of #tumourbiology & clincial outcomes.
Read it here: https://t.co/PkjYiEzqU9 https://t.co/lnMGxbjMJ3
Good CAF or bad CAF, that's the question! In our new paper @Cancer_Cell we use #imagingmasscytometry to unravel the prognostic effect of cancer-associated #fibroblast (CAF) heterogeneity&their effect on therapy in 1000+ @Unispital_USZ lung cancer patients
https://t.co/Z34VrXBCDU